6-Bromo-7-methoxy-2-methylquinazolin-4(3H)-one, 97.0%, 250mg

(4R,5R)-4,5-Diphenyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole, 95%, 250mg

6-Bromo-2H-1,4-benzoxazin-3(4H)-one>94.0%(GC)1g

4-[6-Methyl-4-(trifluoromethyl)pyridin-2-yl]benzoic acid, 95.0%, 1g

1-(4-(Aminomethyl)phenyl)ethanone hydrochloride, 95.0%, 5g

2-(2-Chlorophenyl)benzimidazole>98.0%(GC)(T)25g

3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(trifluoromethyl)phenyl]amino]-3-cyclobutene-1,2-dione, 97%, 50mg

Sodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate xhydrate, 95.0%, 10g

Dansyl-L-leucine, 98%, 1g

N-(2,4-Dinitrophenyl)-L-serine, 98%, 5g

n-Hexane, min. 95%, for synthesis, 25 l, tinplate

2-(4-Methylpiperazin-1-yl)pyrimidin-5-amine, 95.0%, 250mg

1-Bromo-4-(pentafluoroethyl)benzene, 97.0%, 25g